Business
Roivant to Report Financial Results for the Quarter Ended December 31, 2021 on Monday, February 14, 2022
Quarterly investor call and webcast scheduled for Monday, February 14 at 8:00 a.m. ETRoivant will also present at the SVB Leerink Global Healthcare Conference
About this update from Roivant Sciences Ltd.
[{"type":"text","content":"Quarterly investor call and webcast scheduled for Monday, February 14 at 8:00 a.m. ETRoivant will also present at the SVB Leerink Global Healthcare Conference in February, and the Truist AI Symposium and Cowen Healthcare Conference in March BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV), a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, February 14, 2022 to report its third quarter 2021 financial results and provide a corporate update. To access the live conference call, please dial +1-844-224-1923 (domestic) or +1-214-989-7105 (international) and use conference ID 8648616. A webcast of the call will also be available under “Events & Presentations” in the Investors section of the Roivant website at https://investor.roivant.com/news-events/events. The archived webcast will be available on Roivant’s website after the conference call. Roivant also announced its participation in the following upcoming investor conferences: SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 1:00 p.m. ETTruist AI Symposium on Tuesday, March 1, 2022 at 10:10 a.m. ETCowen Healthcare Conference on Tuesday, March 8, 2022 at 9:10 a.m. ET A live webcast of each presentation will be available under “Events & Presentations” in the Investors section of the Roivant website. About Roivant SciencesRoivant's mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity. Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch 'Vants' – nimble and focused biopharmaceutical and health technology companies. For more information, please visit www.roivant.com. Roivant Sciences Forward-Looking StatementsThis press release may contain forward-looking statements regarding our or our management team's expectations, hopes, beliefs, intentions or strategies regarding the future, and statements that are not historical facts, including statements about the clinical and therapeutic potential of our product candidates, the availability and success of topline results from our ongoing clinical trials and a...